Previous in vivo studies have shown that growth hormone (GH) affects vitamin D and mineral metabolism. Insulin-like growth factor-I (IGF-I) was recently reported to be a regulator of renal 1,25-dihydroxyvitamin D 3 (1,25-(OH) 2 D 3 ) production, suggesting that it mediates the effects of GH on vitamin D metabolism. However, there is no direct evidence to support this. The present study was designed to investigate the in vitro effects of GH and IGF-I on the renal production of 1,25- (OH) produced were determined after lipid extraction and HPLC purification. Production of 1,25-(OH) 2 D 3 and 24,25-(OH) 2 D 3 was increased after both IGF-I and GH preincubation in a dose-dependent manner. Significant increases were found after preincubation with 13 nmol/l IGF-I (1,25-(OH) 2 D 3 , 1.8-fold; 24,25-(OH) 2 D 3 , 1.5-fold) or 0.9 or 9 nmol/l GH (1,25-(OH) 2 D 3 , 1.3-fold and 1.5-fold; 24,25-(OH) 2 D 3 , 1.4-fold and 1.5-fold respectively). Furthermore, the effect of 9 nmol/l GH on 1,25-(OH) 2 D 3 and 24,25-(OH) 2 D 3 production was blocked in the presence of IGF-I receptor monoclonal antibody. These results confirm that IGF-I acts on renal tubules, resulting in induction of 1,25-(OH) 2 D 3 and 24,25-(OH) 2 D 3 production, and the findings suggest that GH stimulates 1,25-(OH) 2 D 3 and 24,25-(OH) 2 D 3 production by increasing local IGF-I production in the kidney.
Introduction
It is well established that the bioactivation of vitamin D involves two successive steps of hydroxylation, the first of which is catalysed by 25-hydroxylase in the liver, yielding 25-hydroxyvitamin D 3 ). 25-OHD 3 is physiologically converted into 1a-or 24-dihydroxyvitamin D 3 (1,25-(OH) 2 D 3 and 24,25-(OH) 2 D 3 ) mostly in kidney proximal tubular cells in non-pregnant mammals (1) (2) (3) . The direct modulators of the production of 1,25-(OH) 2 D 3 , the most active form of vitamin D 3 , are parathyroid hormone (PTH), 1,25-(OH) 2 D 3 itself, calcitonin and the extracellular concentrations of calcium and phosphate (1-3). 1,25-(OH) 2 D 3 and PTH were found to be modulators of 24-hydroxylation (2-4), the biological significance of which is controversial (5, 6) . Growth hormone (GH) has been demonstrated to act on mineral metabolism, increasing intestinal absorption and urinary phosphate reabsorption (7) (8) (9) . The similarity between vitamin D and GH with regard to mineral metabolism suggests that GH exerts, at least in part, its effects by modulating vitamin D metabolism.
A number of observations seem to support this hypothesis. GH has been shown to restore the formation of 1,25-(OH) 2 D 3 which is reduced by hypophysectomy in rats (10) (11) (12) . Treatment with rat GH normalized the conversion of 25-OHD 3 to 24,25-(OH) 2 D 3 , which was markedly increased in hypophysectomized rats (12) . Similar results have been found in pigs (13) . It is well established in clinical studies that high-dose GH produces increased serum 1,25-(OH) 2 D 3 levels after both short-term (8, 14, 15) and long-term administration (9, 16) . We found that GH therapy caused decreased serum 24,25-(OH) 2 D 3 levels (9), similar to results obtained in animal studies (12, 13) . This action of GH has been suggested to be mediated by insulin-like growth factor-I (IGF-I) (17) (18) (19) . Indeed, recent studies have shown that IGF-I stimulates 1a-hydroxylase (1a-OHase) activity in vivo and in vitro (20) (21) (22) (23) . However, it has not yet been investigated whether GH directly influences renal vitamin D metabolism.
To elucidate the regulation of 25-OHD 3 metabolism in the kidney and the relation between growth and vitamin D metabolism, the present study was designed to define the in 
Materials and methods

Materials
Cell culture
LLC-PK1 cells were originally obtained from Health Science Research Resources Bank (Osaka, Japan). Cells were grown in 10 cm plastic trays in medium containing 1:1 (v/v) Dulbecco's modified Eagle's medium and Ham's F-12, supplemented with 5% fetal bovine serum. This medium contains 1 mmol/l phosphate and 1 mmol/l calcium. All cultures were maintained at 37 ЊC under 5% CO 2 /95% air. Confluence was generally reached within 6-7 days, and the assays were performed on the 7th or 8th day.
Metabolism of 25-OHD 3
On the day before the experiment, the culture medium was changed and the cells were preincubated for 24 h in serum-free medium with vehicle or hormone (IGF-I or GH).
After preincubation, the medium was removed and the monolayers were rinsed with Ca/Mg-free PBS. The cells were harvested with trypsin/EDTA and washed with fresh medium. The resuspended cells (in 4 ml medium) were transferred to glass tubes containing 75 pmol 25-[ 3 H]OHD 3 , dried under nitrogen, provided as substrate. Incubation was continued in a shaking water bath at 37 ЊC for 4 h unless otherwise indicated. The reaction was terminated by the addition of 3 ml methanol/chloroform (1:1, v/v). Vitamin D metabolites were extracted and separated by previously described methods (24) as follows.
Briefly, the chloroform phases were dried under nitrogen, and the residues redissolved in 1 ml hexane/ isopropanol (96:4, v/v) and applied to Sep-Pak silica cartridges prewashed successively with 5 ml methanol, 5 ml chloroform, 5 ml hexane and 5 ml hexane/ isopropanol (96:4, v/v). fractions yielded by the straight-phase and continuous straight-reversed phase HPLC systems showed good correlation (data not shown). Therefore enzyme activities are expressed using radioactivity values yielded by straight-phase HPLC.
The intra-assay coefficient of variation was less than 10%, and the interassay coefficient of variation was less than 15% for 1,25-(OH) 2 D 3 and 24,25-(OH) 2 D 3 in this assay system. All experiments were performed in duplicate. The results are expressed as pmol/mg protein.
Statistics
Statistical analysis was performed using ANOVA (Fisher's PLSD) in the computer program Statview J 4.02 (Abacus Concepts, Berkeley, CA, USA). Results are given as the meanϮS.E.M. P<0.05 was considered significant.
Results
Metabolism of 25-OHD 3 by LLC-PK1 cells
The untreated cells were able to convert 25-OHD 3 into more polar metabolites. The elution profile of the straight-phase HPLC is shown in Fig. 1a . The major polar metabolite (peak I) was co-eluted with synthetic EUROPEAN JOURNAL OF ENDOCRINOLOGY (1998) 139
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24,25-(OH) 2 D 3 , and a small peak (peak II) was detected at the same elution position as synthetic 1,25-(OH) 2 D 3 . These two fractions were rechromatographed by reverse-phase HPLC. Figure 1b shows the profile of the reverse-phase HPLC of peak I, which was co-eluted with synthetic 24,25-(OH) 2 D 3 . The profile of peak II on the reverse-phase column showed a single peak which was co-eluted with synthetic 1,25(OH) 2 D 3 (Fig. 1c) . Fig. 2 . The incubation was performed for 1ϳ5 h, and the production of both metabolites reached a plateau at 4 h.
Effect of IGF-I and GH on 1,25-(OH) 2 D 3 and 24,25-(OH) 2 D 3 production
Exogenous recombinant human IGF-I increased the amount of 1,25- (Fig. 3) . Incubation of the cells for 24 h with human IGF-I at concentrations between 0.13 and 13 nmol/l stimulated both 1,25-(OH) 2 D 3 and 24,25-(OH) 2 D 3 production in a dose-dependent manner, with significant stimulation at 13 nmol/l (Fig. 4) . Recombinant porcine GH at concentrations between 0.09 and 9 nmol/l in a 24 h preincubation with the cells also stimulated 1,25-(OH) 2 D 3 and 24,25-(OH) 2 D 3 production. Significant stimulation occurred at 0.9 and 9 nmol/l GH (Fig. 5) . Furthermore, the maximal stimulation caused by preincubation with 9 nmol/l GH was completely blocked by the addition of 1 mg/ml IGF-I receptor antibody for both 1,25-(OH) 2 D 3 and 24,25-(OH) 2 D 3 production (Fig. 5 ).
Discussion
We demonstrate the modulation of dihydroxyvitamin D 3 production in a mammalian kidney cell EUROPEAN The LLC-PK1 cells were originally derived from the kidneys of Hampshire pigs (25) , and are shown to express 1,25-(OH) 2 GH and/or IGF-I have been observed in previous in vivo studies to increase serum 1,25-(OH) 2 D 3 levels and 1a-OHase activity in humans and animals (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) 23) . IGF-I is suggested to mediate the GH-dependent increase in serum 1,25-(OH) 2 D 3 , as it can restore the increase in serum 1,25-(OH) 2 D 3 induced by restriction of dietary phosphorus to the same dgree as GH (18) . Further studies are required to determine whether similar results are also observed in vitro.
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Recent in vitro studies have shown stimulatory effects of IGF-I on renal 1,25-(OH) 2 D 3 production. Condamine et al. (21) observed a local action of exogenous IGF-I on 1,25-(OH) 2 D 3 production in LLC-PK1 cells, which may act by different mechanisms on phosphate deprivation. Menaa et al. (22) reported that the stimulatory effect of IGF-I on 1,25-(OH) 2 D 3 production is a calcium-dependent effect in primary mouse kidney cells, unlike that induced by PTH, which involves the cAMP and/or the protein kinase C pathway. The present study also confirmed that IGF-I is an upregulator of renal 1a-OHase. In addition, the stimulatory effect on 1,25-(OH) 2 D 3 production was also observed in GH-treated cells. This effect occurred in a dosedependent manner, like that induced by IGF-I, with significant stimulation observed with large doses of GH (0.9 and 9 nmol/l). IGF-I receptor antibody (clone aIR3) recognizes the a-subunits of the IGF-I receptor, and blocks the signal transduction of IGF-I in a wide series of cell lines (27) (28) (29) . In the present study, we used it to block IGF-I binding to its receptor in LLC-PK1 cells. The stimulatory effect of GH on 1,25-(OH) 2 D 3 and 24,25-(OH) 2 D 3 production was completely blocked by this IGF-I receptor antibody. IGF-I expression in pig kidney has previously been demonstrated (30) . Thus previous reports plus the present observations strongly suggest that GH indirectly affects 1,25-(OH) 2 D 3 production in the kidney by increasing local production of IGF-I. Furthermore, we suggest that the elevated serum levels of 1,25-(OH) 2 D 3 induced by GH administration in vivo are secondary to increased IGF-I production in the liver and other tissues. To confirm these suggestions, mRNA expression must be determined, which requires cloning of the enzyme of this cell line.
24,25-(OH) 2 D 3 production was also observed in this study, and also a stimulating effect on the 24-OHase system by IGF-I and GH treatment. In contrast, we have previously observed decreased serum levels of 24,25-(OH) 2 D caused by GH administration in GHdeficient children (9) , similar to results obtained in animal studies (12, 13) . Wu et al. (31) observed decreased 24-OHase mRNA levels after administration of GH and IGF-I in hypophysectomized rats fed a high phosphate diet, suggesting that the condition of the supplied phosphate may play a key role in the regulation of 24-OHase activity by GH and/or IGF-I in vivo. Iida et al. (32) Thus, theoretically, the production of one of these two metabolites, but not both, is increased. The discrepancy between the present and previous studies can be explained as follows. First, in no study have these two hydroxylases been simultaneously observed in this cell line until now. Either the 'switching' role played by the vitamin D receptor has been lost in our experimental system or the study period of 4 h is too short to 'switch' it on if it does exist. Secondly, changes in other factors caused by GH administration in vivo that affect vitamin D metabolism (such as PTH and phosphate) may also play a role in the variation in serum 24,25-(OH) 2 D 3 levels. We suspect that the upregulation of 24,25-(OH) 2 D 3 production in LLC-PK1 cells is, at least in part, a direct stimulatory effect of IGF-I (GH) on 24-OHase, and not only due to induction of 24-OHase by 1,25-(OH) 2 D 3 , because the appearance of the two metabolites occurs at the same time.
In summary, the present observations in a pig kidney cell line confirm that IGF-I acts on renal tubules, resulting in induction of 1,25-(OH) 2 D 3 and 24,25-(OH) 2 D 3 production. We demonstrate that a large dose of GH also stimulates 1,25-(OH) 2 
